Cite
HARVARD Citation
Czepielewski, M. et al. (2021). Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial.. Growth hormone & IGF research. p. . [Online].